46 Followers on Owler

Corvus

Pharmaceuticals is focused on the development of novel agents targeting the immune system to treat patients with cancer... Read more
OverviewCompetitorsFundingInvestmentsNews & Insights

Corvus

Pharmaceuticals is focused on the development of novel agents targeting the immune system to treat patients with cancer... Read more
Corvus President & CEO: Richard A. Miller

President & CEO

Richard A. Miller

CEO Approval Rating

88/100

2014

PublicNASDAQCRVS

Pharmaceuticals & Biotechnology
BiotechnologyPharmaceuticals
28362834 NAICS listing

Annual Revenue
$ < 1M
Employees
30
Funding
$354.5M
Investments
1

News

Funding
Jan 23, 2026
Nasdaq
Corvus received $175M in Post-IPO Equity Funding
ESG
Jan 20, 2026
iNVEZZ
What made Corvus stock double on Tuesday and is it sustainable?

Corvus Competitors

1NexImmune
2Altor BioScience
3Mustang Bio
4Adaptimmune
5Novartis
6Kite Pharma
7Juno Therapeutics
8Bristol-Myers Squibb
9Fate Therapeutics
10Gilead Sciences
Unlock 9 + competitors

Trending Companies